Pyrimido[1,2-a]-purin-10(3H)-one, M1G, is less prone to artifact than base oxidation

Yo-Chan Jeong1, Jun Nakamura, Patricia B Upton

  • 1Department of Environmental Sciences and Engineering, The University of North Carolina at Chapel Hill, NC 27599-7431, USA.

Nucleic Acids Research
|November 12, 2005
PubMed

Insights

Measuring pyrimido[1,2-a]-purin-10(3H)-one (M1G) reliably assesses oxidative DNA damage. DNA isolation methods do not artifactually alter M1G levels, suggesting previous studies may have overestimated background damage.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • Pyrimido[1,2-a]-purin-10(3H)-one (M1G) is a DNA adduct formed by reactive oxygen species (ROS).
  • Understanding M1G formation and stability during DNA isolation is crucial for accurate oxidative DNA damage assessment.
  • Previous reports may have overestimated background M1G levels.

Purpose of the Study:

  • To investigate artifactual formation or loss of M1G during DNA isolation.
  • To determine the reliability of M1G as a biomarker for oxidative DNA damage.
  • To compare M1G levels in nuclear and mitochondrial DNA.

Main Methods:

  • Investigated the impact of antioxidants, low-temperature DNA isolation, and non-phenol extraction methods on M1G adducts.
  • Quantified M1G adducts in nuclear DNA from various rat tissues (brain, liver, kidney, pancreas, lung, heart).
  • Compared M1G levels in mitochondrial and nuclear DNA from rat liver tissue.

Main Results:

  • DNA isolation procedures (antioxidants, low temperature, non-phenol extraction) did not significantly affect M1G adduct levels.
  • Baseline M1G adducts varied across rat tissues, with the highest in the heart (4.2 M1G/10^8 nt).
  • Mitochondrial DNA showed a 2-fold higher M1G content than nuclear DNA in rat liver.

Conclusions:

  • M1G adduct measurement is a reliable indicator of ROS-induced DNA damage, independent of DNA isolation procedures.
  • The number of M1G adducts is significantly influenced by ROS production.
  • Background M1G levels in genomic DNA may have been overestimated in prior studies by one to three orders of magnitude.

Related Concept Videos

Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase I Oxidative Reactions: Overview01:19

Phase I Oxidative Reactions: Overview

Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Basicity of Heterocyclic Aromatic Amines01:25

Basicity of Heterocyclic Aromatic Amines

Heterocyclic amines, where the N atom is a part of an alicyclic system, are similar in basicity to alkylamines. Interestingly, the heterocyclic amine having a nitrogen atom as part of an aromatic ring has much less basicity than its corresponding alicyclic counterpart. For this reason, as presented in Figure 1, piperidine (pKb = 2.8) is significantly more basic than pyridine (pKb = 8.8).
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems01:15

Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...